IPO Trending
SUNRESTSME / NSEListed

Sunrest Lifescience Limited

Incorporated in 2017, Sunrest Lifescience Limited offers a wide range of healthcare and personal care products, including capsules, tablets, syrup, ointment, gel, mouthwash, solution, suspension, dry powders, and toothpaste. Its portfolio covers medicines across multiple therapeutic categories like anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-protozoal, anti-histamine, anti-hypertensive, cosmetics, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory. With 18 registered trademarks covering 32 products, Sunrest Lifescience is focused on delivering high-quality and effective formulations to its customers.

₹84 - ₹8447.51x sub
Listed Price84.00
Listing Gain+0.00%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Jun 2023)563.58 Cr
Growth-66.7%
Revenue Trend (₹ in Crores)
0.01.0k2.1k3.1kMar 2021Mar 2022Mar 2023Jun 2023
PeriodRev (Cr)PAT (Cr)AssetsDebt
Jun 2023563.5875.081,706.28347.32
Mar 20232,467.05204.311,671.37214.32
Mar 20222,690.9977.711,301.97323.83
Mar 20211,694.9116.55948.15231.55
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values6.8153%98%12.3312